When evaluated by in vitro studies, the metabolism of<unk>  was minimally impacted by the human hepatic CYP450 system. Further investigations with either inducers or inhibitors of this enzyme system demonstrated no changes in the elimination or clearance of<unk> , and the metabolism of model compounds of these CYP systems was not altered by the<unk> . Hydroxy-dalbavancin, a minor metabolite that has only been identified in urine, was also not changed in its formation or elimination with these enzyme models.
Dalbavancin
Rifampicin
Meropenem
Imipenem
Amikacin
Doripenem
Imipenem/cilastatin/relebactam
Avibactam